Catalyst Wire Dossier Catalyst Wire Dossier

Nepafenac 0.3% ophthalmic solution

nepafenac · Alcon Research Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nepafenac 0.3% ophthalmic solution, covering 2012-11-30 to 2012-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study Nepafenac 0.3% [Phase 3]

See pricing